收稿日期: 2024-03-28
网络出版日期: 2024-11-19
基金资助
国家自然科学基金项目(82160080);兴滇英才支持计划项目(NWR-MY-2020-011)
Application effect of insertable cardiac monitorin atrial fibrillation monitoring
Received date: 2024-03-28
Online published: 2024-11-19
心房颤动（房颤）是一种以心房激活不协调和心房收缩无效为特征的室上性心律失常，发病率高，常并发卒中、心力衰竭和心动过速致心功能降低诱发心肌病等不良事件，给患者及家庭造成巨大负担。综合管理房颤至关重要，可有效降低房颤病死率、致残率及改善预后。但传统心电图监测大概率漏诊了无症状及阵发性房颤。植入式心电事件监测仪（insertable cardiac monitor，ICM）作为新一代监测工具，可弥补传统心律监测工具缺点，提供实时心律监测心电图并为使用者提供警报。ICM已广泛应用于医学各领域，临床主要应用于不明原因晕厥患者，近年其适应证研究逐渐扩展到房颤监测，但在临床实践中仍未受到重视。结合相关文献，该文就ICM在房颤中的应用及最新研究进展进行综述，结合优缺点进行评估，让医师在临床实践中重视其应用，以期为管理房颤提供帮助。
黄义梅 , 赵璐露 , 华宝桐 . 植入式心电事件监测仪在房颤中的应用及进展[J]. 实用医学杂志, 2024 , 40(21) : 3095 -3100 . DOI: 10.3969/j.issn.1006-5725.2024.21.021
Atrial fibrillation （AF） is a type of supraventricular arrhythmia characterized by uncoordinated atrial activation， ineffective atrial contraction. It has a high incidence rate and is often complicated by stroke， heart failure， and myocardial disease induced by tachycardia， causing a significant burden on patients and their families. Comprehensive management of AF is crucial for effectively reducing mortality， disability， and improving prognosis. However， traditional electrocardiogram （ECG） monitoring often misses asymptomatic and paroxysmal AF at a higher possibility. In recent years， a new device for monitoring AF， insertable cardiac monitor （ICM）， has emerged to overcome the limitations of traditional arrhythmia monitoring， for it provides real-time ECG monitoring and alerts for users. ICMs have been widely used in multiple medical senarios， primarily for patients with unexplained syncope， and recently they are adopted to monitor AF However， its role in AF monitoring has not received significant attention in clinical practice.Based on relevant literature， this article reviews the application effect of ICM in monitoring AF and the latest research progress in the field and evaluates its advantages and disadvantages to provide some references for AF management.
| 1 | SHI S， TANG Y， ZHAO Q， et al. Prevalence and risk of atrial fibrillation in China： A national cross-sectional epidemiological study［J］. Lancet Reg Health West Pac， 2022， 23：100439. doi:10.1016/j.lanwpc.2022.100439 |
| 2 | YUAN K， ZHAO P， WANG L. Molecular mechanism of atrial remodeling in patients with aging atrial fibrillation under the expression of microRNA-1 and microRNA-21［J］. Bioengineered， 2021， 12（2）：12905-12916. doi:10.1080/21655979.2021.2008668 |
| 3 | JANUARY C T， WANN L S， CALKINS H， et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation： A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons［J］. Circulation， 2019， 140（2）：e125-e151. doi:10.1161/cir.0000000000000719 |
| 4 | AGGARWAL G， AGGARWAL S， ALLA V， et al. Subcutaneouscardiac Rhythm Monitors A Comprehensive Review［J］. JAFIB， 2021， 13（5）：2387. doi:10.4022/jafib.2387 |
| 5 | ASSAF A， THEUNS D A， MICHELS M， et al. Usefulness of insertable cardiac monitors for risk stratification： current indications and clinical evidence［J］. Expert Rev Med Devices， 2023， 20（2）：85-97. doi:10.1080/17434440.2023.2171862 |
| 6 | UNGAR A， PESCINI F， RAFANELLI M， et al. Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors［J］. Eur J Intern Med， 2021， 92：86-93. doi:10.1016/j.ejim.2021.06.022 |
| 7 | SCHNABEL R B， HAEUSLER K G， HEALEY J S， et al. Searching for Atrial Fibrillation Poststroke： A White Paper of the AF-SCREEN International Collaboration［J］. Circulation， 2019， 140（22）：1834-1850. doi:10.1161/circulationaha.119.040267 |
| 8 | HINDRICKS G， POTPARA T， DAGRES N， et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery （EACTS）： The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology （ESC） Developed with the special contribution of the European Heart Rhythm Association （EHRA） of the ESC［J］. Eur Heart J， 2020， 42（5）：373-498. doi:10.1093/eurheartj/ehaa612 |
| 9 | LU Y， DIAO S S， HUANG S J， et al. Insertable cardiac monitors for detection of atrial fibrillation after cryptogenic stroke： a meta-analysis［J］. Neurol Sci， 2021， 42（10）：4139-4148. doi:10.1007/s10072-021-05104-6 |
| 10 | NOUBIAP J J， AGBAEDENG T A， KAMTCHUM-TATUENE J， et al. Rhythm monitoring strategies for atrial fibrillation detection in patients with cryptogenic stroke： A systematic review and meta-analysis［J］. Int J Cardiol Heart Vasc， 2021， 34：100780. doi:10.1016/j.ijcha.2021.100780 |
| 11 | NOUBIAP J J， THOMAS G， MIDDELDORP M E， et al. Atrial fibrillation detection using insertable cardiac monitor after stroke： A real-world cohort study［J］. J Cardiovasc Electrophysiol， 2023， 34（1）：142-146. doi:10.1111/jce.15744 |
| 12 | RATAJCZAK-TRETEL B， LAMBERT A T， AL-ANI R， et al. Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke （NOR-FIB） study - the importance of comprehensive clinical evaluation［J］. BMC Neurol， 2023， 23（1）：115. doi:10.1186/s12883-023-03155-0 |
| 13 | ILIODROMITIS K， LENARCZYK R， SCHERR D， et al. Patient selection， peri-procedural management， and ablation techniques for catheter ablation of atrial fibrillation： an EHRA survey［J］. Europace， 2023， 25（2）：667-675. doi:10.1093/europace/euac236 |
| 14 | FALASCONI G， PENELA D， SOTO-IGLESIAS D， et al. Personalized pulmonary vein antrum isolation guided by left atrial wall thickness for persistent atrial fibrillation［J］. Europace， 2023， 25（5）： euad118. doi:10.1093/europace/euad118 |
| 15 | YAMAGUCHI Y， SOHARA H， TAKEDA H， et al. Long-Term Results of Radiofrequency Hot Balloon Ablation in Patients With Paroxysmal Atrial Fibrillation： Safety and Rhythm Outcomes［J］. J Cardiovasc Electrophysiol， 2015， 26（12）：1298-1306. doi:10.1111/jce.12820 |
| 16 | MASUDA M， ASAI M， IIDA O， et al. Additional low‐voltage‐area ablation in patients with paroxysmal atrial fibrillation： results of the randomized controlled VOLCANO trial［J］. J Am Heart Assoc， 2020， 9（13）：e015927. doi:10.1161/JAHA.120.015927 |
| 17 | SCHIAVONE M， GASPERETTI A， MONTEMERLO E， et al. Long-term comparisons of atrial fibrillation ablation outcomes with a cryoballoon or laser-balloon： A propensity-matched analysis based on continuous rhythm monitoring［J］. Hellenic J Cardiol， 2022， 65：1-7. doi:10.1016/j.hjc.2022.03.006 |
| 18 | LEE S H， KIM T H， OH Y S， et al. Usefulness of an Implantable Loop Recorder in Diagnosing Unexplained Syncope and Predictors for Pacemaker Implantation［J］. J Korean Med Sci， 2020， 35（2）：e11. doi:10.3346/JKMS.2020.35.E11 |
| 19 | SULKE N， SUGIHARA C， HONG P， et al. The benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope： the EaSyAS Ⅱ trial［J］. Europace， 2016， 18（6）：912-918. doi:10.1093/europace/euv228 |
| 20 | 熊雁， 刘明江， 陶剑虹， 等. 不明原因晕厥患者基于长程心电数据的病因分析［J］.中华心律失常杂志， 2023， 27（1）： 66-70. |
| 21 | LETSAS KP， SAPLAOURAS A， MILILIS P， et al. Diagnostic yield of implantable loop recorders： Results from the Hellenic registry［J］. Hellenic J Cardiol， 2024， S1109-9666（24）00108-8. doi:10.1016/j.hjc.2024.05.004 |
| 22 | GIADA F， GULIZIA M， FRANCESE M， et al. Recurrent unexplained palpitations （RUP） study comparison of implantable loop recorder versus conventional diagnostic strategy［J］. J Am Coll Cardiol， 2007， 49（19）：1951-1956. doi:10.1016/j.jacc.2007.02.036 |
| 23 | 中华医学会心电生理和起搏分会， 中国医师协会心律学专业委员会， 中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动：目前的认识和治疗建议（2021）［J］. 中华心律失常学杂志， 2022， 26（1）：74. doi:10.3760/cma.j.cn113859-20211224-00264 |
| 24 | POTPARA T S， LIP G Y H， BLOMSTROM-LUNDQVIST C， et al. The 4S-AF Scheme （Stroke Risk； Symptoms； Severity of Burden； Substrate）： A Novel Approach to In-Depth Characterization （Rather than Classification） of Atrial Fibrillation［J］. Thromb Haemost， 2021， 121（3）：270-278. doi:10.1055/S-0040-1716408 |
| 25 | BRIOSA E GALA A， POPE M， LEO M， et al. Accuracy of AF burden detection with the new Confirm Rx with Sharp-sense technology［J］. EP Europace， 2022. DOI：10.1093/europace/euac053.173 . |
| 26 | ASSAF A， THEUNS D， SAKHI R， et al. Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation： Results of the BioVAD study［J］. Ann Noninvasive Electrocardiol， 2022， 27（3）：e12960. doi:10.1111/anec.12960 |
| 27 | DE WITH R R， ERKüNER ?， RIENSTRA M， et al. Temporal patterns and short-term progression of paroxysmal atrial fibrillation： data from RACE V［J］. Europace， 2020， 22（8）：1162-1172. doi:10.1093/europace/euaa123 |
| 28 | KAPLAN R M， KOEHLER J， ZIEGLER P D， et al. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA（2）DS（2）-VASc Score［J］. Circulation， 2019， 140（20）：1639-1646. doi:10.1161/circulationaha.119.041303 |
| 29 | 王斌，胡丹，王芳芳. 血清尿酸及脑钠肽水平与射血分数保留心衰房颤患者房颤结构重构关系［J］. 实用医学杂志， 2023， 39（20）：2633-2637. doi:10.3969/j.issn.1006-5725.2023.20.014 |
| 30 | HINDRICKS G， POTPARA T， DAGRES N， et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery （EACTS）： The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology （ESC） Developed with the special contribution of the European Heart Rhythm Association （EHRA） of the ESC［J］. Eur Heart J， 2021， 42（5）：373-498. doi:10.1093/eurheartj/ehaa945 |
| 31 | 张鹏祥，杜王，张郝，等. 抗凝治疗与房颤患者血浆神经源性外泌体中T?tau 蛋白和Aβ1?42含量变化的关系［J］. 实用医学杂志， 2022， 38（4）：459-463. |
| 32 | QURASHI A A AL， RASHEED F， SIDDIQI A R， et al. Insertable cardiac monitoring devices versus external cardiac monitoring for detecting atrial fibrillation and preventing the recurrence of stroke： A systematic review and meta-analysis［J］. J Electrocardiol， 2023， 77：29-36. doi:10.1016/j.jelectrocard.2022.11.007 |
| 33 | 梁士楚， 王翠， 宋晨宇，等. 心房颤动射频消融术后长期抗凝可行性及安全性的Meta分析和试验序贯分析［J］. 中国循环杂志， 2020， 35（11）：1121-1128. |
| 34 | FRIBERG L， TABRIZI F， ENGLUND A. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death： data from Swedish health registries［J］. Eur Heart J， 2016， 37（31）：2478-2487. doi:10.1093/eurheartj/ehw087 |
| 35 | ARAI M， OKUMURA Y， NAGASHIMA K， et al. Adverse Clinical Events during Long-Term Follow-Up After Catheter Ablation of Atrial Fibrillation［J］. Int Heart J， 2019， 60（4）：812-821. doi:10.1536/ihj.18-517 |
| 36 | POTHINENI N V K， AMANKWAH N， SANTANGELI P， et al. Continuous rhythm monitoring-guided anticoagulation after atrial fibrillation ablation［J］. J Cardiovasc Electrophysiol， 2021， 32（2）：345-353. doi:10.1111/jce.14864 |
| 37 | WILLEMS S， BOROF K， BRANDES A， et al. Systematic， early rhythm control strategy for atrial fibrillation in patients with or without symptoms： the EAST-AFNET 4 trial［J］. Eur Heart J， 2022， 43（12）：1219-1230. doi:10.1093/eurheartj/ehab593 |
| 38 | KUNISS M， PAVLOVIC N， VELAGIC V， et al. Cryoballoon ablation vs. antiarrhythmic drugs： first-line therapy for patients with paroxysmal atrial fibrillation［J］. Europace， 2021， 23（7）：1033-1041. doi:10.1093/europace/euab029 |
| 39 | BERLIN S， GOETTE A， SUMMO L， et al. Assessment of OMT-28， a synthetic analog of omega-3 epoxyeicosanoids， in patients with persistent atrial fibrillation： Rationale and design of the PROMISE-AF phase Ⅱ study［J］. Int J Cardiol Heart Vasc， 2020， 29：100573. doi:10.1016/j.ijcha.2020.100573 |
| 40 | CHU A F， RAJAGOPAL G， SARKAR S. The missing link： Unlocking the power of cardiac rhythm monitoring device based QT interval detection［J］. Pacing Clin Electrophysiol， 2022， 45（3）：401-409. doi:10.1111/pace.14431 |
| 41 | STOLEN C， ROSMAN J， MANYAM H， et al. Preliminary results from the LUX-Dx insertable cardiac monitor remote programming and performance （LUX-Dx PERFORM） study［J］. Clin Cardiol， 2023， 46（1）：100-107. doi:10.1002/clc.23930 |
| 42 | IBRAHIM O A， DREW D， HAYES C J， et al. Implantable loop recorders in the real world： a study of two Canadian centers［J］. J Interv Card Electrophysiol， 2017， 50（2）：179-185. doi:10.1007/s10840-017-0294-y |
| 43 | AFZAL M R， MEASE J， KOPPERT T， et al. Incidence of false-positive transmissions during remote rhythm monitoring with implantable loop recorders［J］. Heart Rhythm， 2020， 17（1）：75-80. doi:10.1016/j.hrthm.2019.07.015 |
| 44 | DE COSTER M， DEMOLDER A， DE MEYER V， et al. Diagnostic accuracy of R-wave detection by insertable cardiac monitors［J］. Pacing Clin Electrophysiol， 2020， 43（5）：511-517. doi:10.1111/pace.13912 |
| 45 | CHENG Y-J， OUSDIGIAN KT， SARKAR S， et al. B-Po04-036 innovative artificial intelligence application reduces false pause alerts while maintaining perfect true pause alert sensitivity for insertable cardiac monitors［J］. Heart Rhythm， 2021， 18（8）：S293-S294. doi:10.1016/j.hrthm.2021.06.732 |
| 46 | TANKUT S S， HUANG D T， ZAREBA W， et al. Insertable cardiac monitor-guided early intervention to reduce atrial fibrillation burden following catheter ablation： Study design and clinical protocol （ICM-REDUCE-AF trial）［J］. Ann Noninvasive Electrocardiol， 2023， 28（2）：e13043. doi:10.1111/anec.13043 |
| 47 | QUARTIERI F， HARISH M， CALò L， et al. New insertable cardiac monitors show high diagnostic yield and good safety profile in real-world clinical practice： results from the international prospective observational SMART Registry［J］. Europace， 2023， 25（5）： euad068. doi:10.1093/europace/euad068 |
/
| 〈 |
|
〉 |